Treatment of psychiatric disorders in children and adolescents with HIV/AIDS

Current Psychiatry Reports

Volumn 12, Issue 2, 2010, Pages 104-110

  Benton, Tami D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adolescent HIV; Adolescents; HIV AIDS; Mental health; Psychiatric disorders

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLONAZEPAM; EFAVIRENZ; FLUOXETINE; HALOPERIDOL; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; NORFLUOXETINE; PSYCHOSTIMULANT AGENT; RITONAVIR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; COGNITIVE THERAPY; DELIRIUM; DEMENTIA; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; MENTAL DISEASE; MOOD DISORDER; PAIN; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOTHERAPY; REVIEW; SEDATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; YOUNG ADULT;

EID: 77953536856     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-010-0092-z     Document Type: Review

References (39)

1. Centers for Disease Control and Prevention (CDC): HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:1073-1076.
2. Hall HI, Song R, Rhodes P, et al.: Estimation of HIV incidence in the United States. JAMA 2008, 300:520-529.
3. UNAIDS 2004: 2004 report on the global AIDS epidemic. Available at http://www.unaids.org/bangkok2004/GAR2004-html/ GAR2004-00-en.htm. Accessed December 12, 2009.
4. US Department of Health and Human Services, Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report, 2005, vol 17, revised edition. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2007. Also available at http://www.cdc.gov/hiv/topics/ surveillance/resources/ reports/.
5. Donenberg G, Pao M: Youths and HIV/AIDS: psychiatry's role in the changing epidemic. J Am Acad Child Adolesc Psychiatry 2005, 44:728-747.
6. Brown LK, Danokovsy MB, Lourie JK: Adolescents with psychiatric disorders and the risk of HIV. J Am Acad Child Adolesc Psychiatry 1997, 36:1609-1617.
7. Tubman JG, Gil AG, Wagner EF, Artigues H: Patterns of sexual risk behaviors and psychiatric disorders in a community sample of young adults. J Behav Med 2003, 26:473-500.
8. Gaughan DM, HughesMD, Oleske JM, et al.; for the Pediatric AIDS Clinical Trials Group 219C Team: Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics 2004, 113:e544-e551.
9. Scharko AM: DSM psychiatric disorders in the context of pediatric HIV/AIDS. AIDS Care 2006, 18:441-445.
10. Mellins CA, Brackis-Cott E, Leu CS, et al.: Rates and types of psychiatric disorders in perinatally human immunodeficiency virusinfected youth and seroreverters. J Child Psychol Psychiatry 2009, 50:1131-1138. This is the only well-designed and controlled study examining psychiatric disorders among youth with vertically acquired HIV disease.
11. Mellins CA, Smith R, O'Driscoll P, et al.: High rates of behavioral problems in perinatally HIV-infected children are not linked to HIV disease. Pediatrics 2003, 111:384-393.
12. Misdrahi D, Vila G, Funk-Brentano I, et al.: DSV-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1). Eur Psychiatry 2004, 19:182-184.
13. Pao M, Lyon M, D'Angelo LJ, et al.: Psychiatric diagnosis in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med 2000, 154:240-244.
14. Lewinsohn PM, Hops H, Roberts RE, et al.: Adolescent psychopathology I: prevalence and incidence of depression and other DSM-IIIR disorders in high school students. J Abnorm Psychol 1993, 102:133-144. (Published erratum appears in J Abnorm Psychol 1993, 102:517.)
15. Wood SM, Shah SS, Steenhoff AP, Rutstein RM: The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. AIDS 2009, 23:1859-1865.
16. Evans DL, Charney DS, Lewis L, et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
17. Thompson A, Silverman B, Dzeng L, Treisman G: Psychotropic medications and HIV/AIDS. Clin Infect Dis 2006, 42:1305-1310.
18. Pao M, Weiner L: Childhood and adolescence. In Textbook of AIDS Psychiatry. Edited by Cohen M, Gorman J. New York: Oxford University Press; 2009:307-336. This is an excellent review of what is known about HIV/AIDS in both congenitally and behaviorally acquired HIV disease.
19. Emslie GJ, Rush J, Weinberg WA, et al.: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997, 54:1031-1037.
20. Geller B, Reising D, Leonard HL, et al.: Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38:513-516.
21. Rosenstein DR, Pao M, Cai J: Psychopharmacologic management in oncology. In Bethesda Handbook of Clinical Oncology, edn 2. Edited by Abraham J, Allegra CJ, Gulley J. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:521-528.
22. Geller B, Zimmerman B, Williams M: Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality. J Child Adolesc Psychopharmacol 2002, 12:3-9.
23. Kowatch RA, DelBello MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc Psychiatr Clin N Am 2006, 15:73-108.
24. Fernandez F, Levy JK, Samley HR, et al.: Effects ofmethylphenidate in HIV-related depression: a comparative trial with desipramine. Int J Psychiatry Med 1995, 25:53-67.
25. Seidel L, Walkup JT: Selective serotonin reuptake inhibitor use in the treatment of pediatric non-obsessive-compulsive disorder anxiety disorders. J Child Adolesc Psychopharmacol 2006, 16:171-179.
26. Havens JF, Mellins CA: Psychiatric aspects of HIV/AIDS in childhood and adolescence. In Child and Adolescent Psychiatry, edn 5. Edited by Rutter M, Taylor E. Oxford,: Blackwell; 2008:600-615.
27. Stuber M, Shemesh E, Saxe GN: Post-traumatic stress and responses in children with life-threatening illnesses. Child Adolesc Psychiatr Clin N Am 2003, 12:195-209.
28. Radcliffe J, Fleisher CL, Hawkins LA, et al.: Posttraumatic stress and trauma history in adolescents and young adults with HIV. AIDS Patient Care STDS 2007, 21:501-508.
29. Cohen J, Berliner L, March JS: Treatment of children and adolescents. In Effective Treatments for PTSD: Practice Guidelines From the International Society for Traumatic Stress Studies. Edited by Foa EB, Keane TM, Friedman MJ. New York: Guilford Press; 2000:330-332.
30. Turkel SB, Tavaré CJ: Delirium in children and adolescents. J Neuropsychiatry Clin Neurosci 2003, 15:431-435.
31. Scharko AM, Baker EH, Kothari P, et al.: Case study: delirium in an adolescent girl with human immunodeficiency virus-associated dementia. J Am Acad Child Adolesc Psychiatry 2006, 45:104-108.
32. McArthur JC: HIV dementia: an evolving disease. J Neuroimmunol 2004, 157:3-10.
33. Belman A: HIV-1 associated CNS disease in infants and children. In Research Publications: Association for Research in Nervous and Mental Disease. Edited by Price R, Perry S III. New York: Raven Press; 1994:289-310.
34. Carrico AW, Antoni MH: Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials. Psychosom Med 2008, 70:575-584.
35. Rotheram-Borus MJ, Murphy DA, Wight RG, et al.: Improving the quality of life among young people living with HIV. Eval Program Plann 2001, 24:227-237.
36. Brown LK, Schultz JR, Parsons JT, et al.: Sexual behavior change among human immunodeficiency virus-infected adolescents with hemophilia. Adolescent Hemophilia Behavioral Intervention Evaluation Project Study Group. Pediatrics 2000, 106:E22.
37. Murphy DA: Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 2005, 159:764-770.
38. Williams PL: Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006, 118:e1745-e1757.
39. Brown LK, Whiteley LB, Peters AA: HIV and AIDS. In Textbook of Child and Adolescent Psychiatry. Edited by Dulcan MK. Washington DC: American Psychiatric Publishing; 2010:495-508.